Thursday, July 18, 2024
News

Novel drug offers hope for heart failure, sleep apnoea patients

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Wellington | Saturday, 2023 1:45:09 AM IST
Researchers have developed a novel drug that has shown promise for alleviating heart failure and sleep apnoea -- a sleep disorder in which breathing repeatedly stops and starts.

The team from University of Auckland in New Zealand tested the drug, known as AF-130, in an animal model.

They found it improved the heart''s ability to pump, but, equally important, prevented sleep apnoea, which itself reduces lifespan.

"This drug does offer benefit for heart failure, but it''s two for the price of one, in that it''s also relieving the apnoea for which there is currently no drug, only CPAP (a breathing device), which is poorly tolerated," said Professor Julian Paton, director of the University''s Centre for Heart Research.

When a person has a heart attack and subsequent heart failure, the brain responds by activating the sympathetic system, the afight or flight'' response, as a way to stimulate the heart to pump blood.

However, the brain persists with this activation of the nervous system, even when it is no longer required, and this together with the consequent sleep apnoea, contributes to the patient''s reduced life expectancy. Most patients die within five years of a heart failure diagnosis.

"This study has revealed the first drug to temper the nervous activity from the brain to the heart thereby reversing the heart''s progressive decline in heart failure," said Paton.

The part of the brain that sends nervous impulses to the heart is also controlling respiration, so this drug has a dual function, reducing the afight or flight'' response while also stimulating breathing to stop the sleep apnoea.

These findings, described in the journal Nature Communications, have real potential for improving the wellness and life expectancy of people living with heart disease.

The drug will soon undergo human trials in the next year or two, Paton said.

"Over recent decades there have been several classes of drugs that have improved the prognosis of heart failure," said cardiology consultant and Associate Professor, Martin Stiles.

"However, none of these drugs work in the way that this new agent does. So it is exciting to see a novel method that potentially reverses some features of heart failure."

--IANS rvt/vd

A

( 374 Words)

2023-03-31-19:34:04 (IANS)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Autoantibodies can be behind lifelong ri...
Weight loss influences risky decisions i...
New sleep study tries to understand cogn...
Hormone therapy for breast cancer may be...
College of Fisheries Tripura conducts re...
More...
 
INDIA WORLD ASIA
Congress says decline in real wages of w...
Five more suspected cases of Chandipura ...
SC asks NTA to publish NEET-UG result of...
One person dies after explosion occurs a...
'UP govt promoting untouchability': Owai...
Railway Ministry announces compensation ...
More...    
 
 Top Stories
Big B's BTS picture from 'Fakt Puru... 
Delhi: 'Sushasan Samvad Chhattisgar... 
Ajman Crown Prince chairs Ajman Ban... 
CM Dhami approves Rs 130 cr under S... 
Mansour bin Zayed approves Arabian ... 
"I urge court to take suo-motto cog... 
India, Malaysia to increase coopera... 
Odisha: ED attaches assets worth Rs...